|
|
Title | Creator | Description | Identifier |
1 |
|
Headache Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial (abstract) | Deborah I. Friedman, MD, MPH, Professor, Neurology & Neurotherapeutics, University of Texas Southwestern, Peter Quiros, Prem S Subramanian, MD, PhD, Professor of Ophthalmology, Neurology, and Neurosurgery, University of Colorado, Luis Mejico, Michael McDermott | Headache is the most common symptom of IIH. The IIHTT prospectively enrolled 165 participants with mild visual field loss to assess whether acetazolamide (ACZ) plus dietary management was superior to placebo (PBO) tablets plus dietary management in improving visual function [1]. We report the hea... | 20170403_nanos_sciplatform1_02-abstract |
2 |
|
Headache Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial (video) | Deborah I. Friedman, MD, MPH, Professor, Neurology & Neurotherapeutics, University of Texas Southwestern, Peter Quiros, Prem S Subramanian, MD, PhD, Professor of Ophthalmology, Neurology, and Neurosurgery, University of Colorado, Luis Mejico, Michael McDermott | Headache is the most common symptom of IIH. The IIHTT prospectively enrolled 165 participants with mild visual field loss to assess whether acetazolamide (ACZ) plus dietary management was superior to placebo (PBO) tablets plus dietary management in improving visual function [1]. We report the headac... | 20170403_nanos_sciplatform1_02-video |